Pharmaceutical

Moderna pauses plans to build mRNA facility in Kenya

Moderna has announced the halt of its project to build a messenger ribonucleic acid (mRNA) manufacturing facility in Kenya.

Apr 13, 2024 - 00:00
Moderna pauses plans to build mRNA facility in Kenya
Moderna has announced the halt of its project to build a messenger ribonucleic acid (mRNA) manufacturing facility in Kenya.
Read the original article

Tags:

Previous Article

Century secures $60m in stock sale and buys preclinical cell therapy biotech

Next Article

Fujifilm invests $1.2bn ramping up North Carolina facility

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: House subcommittee forays into fixing drug shortages

STAT+: House subcommittee forays into fixing drug short...

Sep 14, 2023

F. Hoffmann-La Roche sees highest patent filings and grants during August in Q3 2023

F. Hoffmann-La Roche sees highest patent filings and gr...

Nov 24, 2023

Pharmaceutical Technology Excellence Awards 2024: BostonGene 

Pharmaceutical Technology Excellence Awards 2024: Bosto...

Nov 13, 2024